According to Intent Market Research, the Alzheimer’s Therapeutics Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 10.7% to touch USD 9.5 billion by 2030. The Alzheimer’s Therapeutics Market is dominated by key players such as Eli Lilly and Co., Biogen Inc., Roche Holding AG, Johnson & Johnson, Novartis AG, copyright Inc., AstraZeneca, Merck & Co., Inc., Sanofi... https://intentmarketresearch.com/latest-reports/alzheimers-therapeutics-market-4861.html